Open access
Open access
Powered by Google Translator Translator

Daily Archives: November 29, 2022

WHO renames “monkeypox” as “mpox” to help destigmatize the disease.

29 Nov, 2022 | 14:27h | UTC

WHO recommends new name for monkeypox disease – World Health Organization

Commentaries:

WHO to phase out the name ‘monkeypox’ for ‘mpox’ – STAT

WHO renames monkeypox as mpox, citing racist stigma – NPR

The Future of Monkeypox – The Atlantic

Monkeypox given new name by global health experts – BBC

Monkeypox to be renamed mpox to avoid stigma, says WHO – The Guardian

 

Commentary on Twitter (thread – click for more)

 


WHO Global tuberculosis report 2022.

29 Nov, 2022 | 14:25h | UTC

Global tuberculosis report 2022 – World Health Organization

News Release: Tuberculosis deaths and disease increase during the COVID-19 pandemic – World Health Organization

Video Summary: WHO Global Tuberculosis Report 2022: Key findings and messages – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


M-A | Thiazide diuretics and fracture risk.

29 Nov, 2022 | 14:23h | UTC

Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials – JBMR Plus

 


Study shows Omicron sublineage BQ.1.1 is resistant to all monoclonal antibodies.

29 Nov, 2022 | 14:16h | UTC

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies – The Lancet Infectious Diseases

Commentaries: 

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies, study finds – Deutsches Primatenzentrum (DPZ)/German Primate Center

Omicron variant BQ.1.1 found to be resistant to all monoclonal antibody treatments – MedicalXpress

Related: BQ.1 and BQ.1.1 are now the dominant COVID variants. What does that mean? – MedicalXpress

 

Commentary on Twitter

 


Opinion | Minimizing administrative harm: a key step to improving health care.

29 Nov, 2022 | 14:21h | UTC

Minimizing administrative harm: a key step to improving health care – STAT

 


Perspective | Eight billion and counting.

29 Nov, 2022 | 14:19h | UTC

Eight Billion and Counting – Think Global Health

 


Near Hanging: evaluation and management.

29 Nov, 2022 | 14:14h | UTC

Near Hanging: evaluation and management – Chest (PDF)

 


Cohort Study | Impact of the trimester of diagnosis on COVID-19 disease progression in pregnancy.

29 Nov, 2022 | 14:18h | UTC

Examining the impact of trimester of diagnosis on COVID-19 disease progression in pregnancy – American Journal of Obstetrics & Gynecology MFM (free for a limited period)

News Release: Risk of severe COVID-19 symptoms remains throughout pregnancy, study finds – UT Southwestern Medical Center

 

Commentary on Twitter

 


The ‘Ten Commandments’ for the 2022 European Society of Cardiology guidelines on cardio-oncology.

29 Nov, 2022 | 14:13h | UTC

The ‘Ten Commandments’ for the 2022 European Society of Cardiology guidelines on cardio-oncology – European Journal of Cardiology

Original guideline: #ESCCongress | 2022 ESC Guidelines on cardio-oncology.

 


Consensus Paper | Hematopoietic cell transplantation in the management of myelodysplastic syndrome.

29 Nov, 2022 | 14:11h | UTC

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines – Transplantation and Cellular Therapy

 


Evidence-based approach to the surgical management of acute pancreatitis.

29 Nov, 2022 | 14:10h | UTC

Evidence-Based Approach to the Surgical Management of Acute Pancreatitis – The Surgery Journal

Related:

Intravenous fluid therapy in patients with severe acute pancreatitis admitted to the intensive care unit: a narrative review – Intensive Care Medicine

Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis – New England Journal of Medicine (link to abstract – $ for full-text)

Acute Pancreatitis: Diagnosis and Treatment – Drugs

Revised Clinical Practice Guidelines of the Korean Pancreatobiliary Association for Acute Pancreatitis – Gut and Liver

Guidelines for the management of patients with severe acute pancreatitis, 2021 – Anaesthesia Critical Care & Pain Medicine

Evidence-Based Disposition of Acute Pancreatitis – emDocs

2019 WSES guidelines for the management of severe acute pancreatitis – World Journal of Emergency Surgery

American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis

Pancreatitis – National Institute for Health and Care Excellence

 


Podcast | Back pain update.

29 Nov, 2022 | 14:07h | UTC

#368 Back Pain Update with
Dr. Austin Baraki – The Curbsiders

 


Review | Thrombolysis in cardiac arrest.

29 Nov, 2022 | 14:08h | UTC

Thrombolysis in Cardiac Arrest – emDocs

 


Podcast | Opioid use disorder and acute pain in hospitalized patients.

29 Nov, 2022 | 14:05h | UTC

#366 Opioid Use Disorder and Acute Pain in the Hospitalized Patient – The Curbsiders

 


Cohort Study | Trends and risk factors for venous thromboembolism among hospitalized medical patients.

29 Nov, 2022 | 14:04h | UTC

Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients – JAMA Network Open

 

Commentary on Twitter

 


Liposomal amphotericin B — Past, present and future.

29 Nov, 2022 | 14:03h | UTC

Foreword

Liposomal amphotericin B—the past – Journal of Antimicrobial Chemotherapy

Liposomal amphotericin B—the present – Journal of Antimicrobial Chemotherapy

Liposomal amphotericin B—the future – Journal of Antimicrobial Chemotherapy

 


SR | Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.

29 Nov, 2022 | 13:59h | UTC

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia – Cochrane Library

Summary: Reduction in the dose of antipsychotics for people with schizophrenia – Cochrane Library

 


M-A | Efficacy and safety of Roxadustat in patients with chronic kidney disease.

29 Nov, 2022 | 14:00h | UTC

Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients – BioMed Research International

Related:

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study – Journal of the American Society of Nephrology

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis – New England Journal of Medicine

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis- New England Journal of Medicine

 


M-A | Risk factors for knee osteoarthritis after traumatic knee injury.

29 Nov, 2022 | 14:02h | UTC

Risk factors for knee osteoarthritis after traumatic knee injury: a systematic review and meta-analysis of randomised controlled trials and cohort studies for the OPTIKNEE Consensus – British Journal of Sports Medicine

Commentary: Risk factors for osteoarthritis after a knee injury – BJSM Blog

 

Commentary on Twitter

 


RCT | Rezafungin vs. caspofungin for treatment of candidaemia and invasive candidiasis.

29 Nov, 2022 | 13:54h | UTC

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial – The Lancet (link to abstract – $ for full-text)

 


Review | Infectious complications of abortion.

29 Nov, 2022 | 13:56h | UTC

Infectious Complications of Abortion – Open Forum Infectious Diseases

 


Review | The complex challenge of antenatal steroid therapy nonresponsiveness.

29 Nov, 2022 | 13:52h | UTC

The complex challenge of antenatal steroid therapy nonresponsiveness – American Journal of Obstetrics & Gynecology

 


Brief Review | Tailoring treatments to older people in intensive care. A way forward.

29 Nov, 2022 | 13:51h | UTC

Tailoring treatments to older people in intensive care. A way forward – Intensive Care Medicine

 

Commentary on Twitter

 


Brief Review | When the kidneys hurt, the other organs suffer.

29 Nov, 2022 | 13:50h | UTC

When the kidneys hurt, the other organs suffer – Intensive Care Medicine (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Prevalence and trend of smokeless tobacco use among adolescents aged 12–16 years in 138 countries/territories.

29 Nov, 2022 | 13:47h | UTC

Prevalence and trend of smokeless tobacco use and its associated factors among adolescents aged 12–16 years in 138 countries/territories, 1999–2019 – BMC Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.